Related Experiment Video
Updated: Jun 1, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
[Giant cell arteritis (temporal arteritis, Horton's arteritis): clinical characteristics and management]
T Rössler1, S Tuchen, W Hofmüller
1Universitätsaugenklinik, Otto-von-Guericke-Universität Magdeburg. tr2@arcor.de
Insights
Giant cell arteritis (Horton's disease) presents varied symptoms, complicating diagnosis. Early detection and treatment are crucial to prevent vision loss, with erythrocyte sedimentation rate (ESR) as a key lab marker.
Area of Science:
- Rheumatology
- Ophthalmology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA), also known as Horton's disease, is a systemic vasculitis.
- GCA presents with heterogeneous symptomatology, often leading to diagnostic challenges.
Observation:
- Ophthalmic and systemic symptoms of GCA can vary significantly between patients.
- Generic symptoms may not always coexist, complicating initial clinical suspicion.
Findings:
- The erythrocyte sedimentation rate (ESR) is a critical laboratory parameter for monitoring GCA.
- While temporal artery biopsy is definitive, imaging techniques like ultrasound and MRI aid diagnosis.
- Prompt, high-dose corticosteroid therapy is essential upon clinical suspicion, regardless of initial lab results.
Implications:
- Early diagnosis and treatment of GCA are vital to prevent severe ophthalmic complications, including blindness.
- Long-term management may require immunosuppressive therapy and multidisciplinary collaboration.
- Treatment involves initial high-dose corticosteroids followed by a slow, ESR-guided dose reduction.
Abstract:
Giant cell arteritis can cause diagnostic difficulties due to its heterogeneous symptomatology. Characteristic ophthalmic and systemic symptoms of Horton's disease are discussed. The clinical course is described on the basis of typical patients, which shows that generic symptoms do not have to coexist. The Horton's arteritis potentially represents a systemic vasculitis that requires early diagnosis and treatment in order to avoid dramatic ophthalmic consequences, in worst cases blindness. The erythrocyte sedimentation rate (ESR) represents the most important laboratory parameter. Although temporal artery biopsy remains the only confirmatory procedure for a definite diagnosis, imaging procedures such as sonography, magnetic resonance imaging, ultrasound biomicroscopy are useful in supporting the clinical diagnosis. Highly dosed corticosteroid therapy should always be indicated when suspicious clinical symptoms are present, even without any dramatic laboratory parameter changes. Initial high dosages are indicated up to 1 gram daily depending on the severity of the disease. Subsequently a slow ESR titrated reduction of the dose is necessary under control of inflammation values, symptomatology and side effects. Occasionally a lifelong immunsuppressive therapy is indispensable. The long-term treatment should take place in close cooperation with the general practitioner, rheumatologist, neurologist and if necessary further specialists.
Related Concept Videos
Tonsillitis II: Management
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care